EPHB3 and colorectal carcinoma: Chiu S.T. et al., analyzing data from patients with advanced CRC, demonstrated a noteworthy downregulation of EPHB3 expression [38], while Ulivi P. et al. demonstrated that EPHB4 was substantially overexpressed in the less-inflammatory, right-sided tumors in comparison with their left-sided counterparts [63].